India to France: Ceftriaxone Export Trade Route

The India to France Ceftriaxone corridor is one of India's established pharmaceutical export routes, with 422 shipments documented worth a combined $8.9M USD. The route is dominated by AJANTA PHARMA LIMITED, which alone accounts for roughly 13% of all export value, reflecting the consolidated nature of India's ceftriaxone manufacturing sector.

Across 55 active suppliers, the average shipment value stands at $21.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with ceftriaxone's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 19.4%, placing it at rank #13 among India's top ceftriaxone export destinations globally.

On the import side, key buyers of Indian ceftriaxone in France include PLANET PHARMA SA, PLANETPHARMA , PLANET PHARMA and 45 others. PLANET PHARMA SA is the single largest importer with 41 shipments valued at $1.2M USD.

India's ceftriaxone exports to France are driven primarily by a handful of large-scale manufacturers. AJANTA PHARMA LIMITED with 42 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 55 active exporters signals a competitive but concentrated market — buyers in France benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — AJANTA PHARMA LIMITED, MACLEODS PHARMACEUTICALS LTD , AJANTA PHARMA LIMITED — together account for 32% of total trade value on this route. The average shipment value of $21.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as accuzon 1g(ceftriaxone for injection usp 1g) vials and celltriaxon 1g-ceftriaxone injection usp, suggesting that buyers in France tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, PLANET PHARMA SA is the largest importer with 41 shipments worth $1.2M USD — representing 14% of all ceftriaxone imports from India on this route. A total of 48 buyers are active on this corridor.